- Substantial competition in the neuro-interventional medical device industry.
- Recently enacted and future legislation (two-invoice system and centralized procurement) may increase costs and difficulty in obtaining regulatory approval and commercializing products.
- Failure to achieve broad market acceptance.
- Maintaining an effective distribution channel.
- Complex manufacturing subject to strict quality controls.
- Potential impairment of intangible assets.
- Need for additional financing to fund operations.
MicroPort NeuroTech Limited
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, MicroPort NeuroTech Limited disclosed greenhouse gas emissions of 1.7K tCO2e/year. By scope: Scope 1: 89.32 tCO2e/year; Scope 2: 1.6K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
1.7K tCO2e/year
2023
Water Usage
34.3K tonnes/year
2023
Waste
96.74 tonnes/year
2023
Energy Use
4.1M kWh/year
2023
📊 Emissions by Scope (2023)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 89.32 tCO2e/year |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 1.6K tCO2e/year |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
✅ Reported Environmental Achievements
- Achieved a 100% eligible disposal rate of hazardous waste, medical waste, general industrial solid waste and domestic waste.
- Localization rate of raw materials for products reached over 90%, with key materials exceeding 85%.
🌱 ESG Focus Areas
Corporate GovernanceInnovation Protecting HealthCooperation and DevelopmentContributing to a Low-Carbon FutureCreating a Pleasant WorkplaceEngaging in Social Welfare